BAYER EXTRA STRENGTH ASPIRIN FOR MIGRAINE PAIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Bayer Extra Strength Aspirin For Migraine Pain, and when can generic versions of Bayer Extra Strength Aspirin For Migraine Pain launch?
Bayer Extra Strength Aspirin For Migraine Pain is a drug marketed by Bayer and is included in one NDA.
The generic ingredient in BAYER EXTRA STRENGTH ASPIRIN FOR MIGRAINE PAIN is aspirin. There are twenty-two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the aspirin profile page.
Summary for BAYER EXTRA STRENGTH ASPIRIN FOR MIGRAINE PAIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 136 |
Clinical Trials: | 10 |
Patent Applications: | 4,002 |
Formulation / Manufacturing: | see details |
DailyMed Link: | BAYER EXTRA STRENGTH ASPIRIN FOR MIGRAINE PAIN at DailyMed |
Recent Clinical Trials for BAYER EXTRA STRENGTH ASPIRIN FOR MIGRAINE PAIN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Postgraduate Institute of Medical Education and Research | Phase 4 |
AgoneX Biopharmaceuticals, Inc. | Phase 2 |
BioHealthonomics Inc. | Phase 2 |
See all BAYER EXTRA STRENGTH ASPIRIN FOR MIGRAINE PAIN clinical trials
US Patents and Regulatory Information for BAYER EXTRA STRENGTH ASPIRIN FOR MIGRAINE PAIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bayer | BAYER EXTRA STRENGTH ASPIRIN FOR MIGRAINE PAIN | aspirin | TABLET;ORAL | 021317-001 | Oct 18, 2001 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |